Letter to the Editor: Liraglutide-Induced Increase in Bone Formation Can Be Dependent on Osteocalcin.
Department of Endocrinology and Metabolism (M.K., S.B., T.D.), Diskapi Teaching and Research Hospital, Ankara, Turkey; Department of Endocrinology and Metabolism (S.K.), Ankara Teaching and Research Hospital, Ankara, Turkey; and Department of Internal Medicine (T.D.), School of Medicine (Kastamonu), Hacettepe University, Ankara, Turkey.
Muhammed
M
Kizilgul
Department of Endocrinology and Metabolism (M.K., S.B., T.D.), Diskapi Teaching and Research Hospital, Ankara, Turkey; Department of Endocrinology and Metabolism (S.K.), Ankara Teaching and Research Hospital, Ankara, Turkey; and Department of Internal Medicine (T.D.), School of Medicine (Kastamonu), Hacettepe University, Ankara, Turkey.
Seyfullah
S
Kan
Department of Endocrinology and Metabolism (M.K., S.B., T.D.), Diskapi Teaching and Research Hospital, Ankara, Turkey; Department of Endocrinology and Metabolism (S.K.), Ankara Teaching and Research Hospital, Ankara, Turkey; and Department of Internal Medicine (T.D.), School of Medicine (Kastamonu), Hacettepe University, Ankara, Turkey.
Selvihan
S
Beysel
Department of Endocrinology and Metabolism (M.K., S.B., T.D.), Diskapi Teaching and Research Hospital, Ankara, Turkey; Department of Endocrinology and Metabolism (S.K.), Ankara Teaching and Research Hospital, Ankara, Turkey; and Department of Internal Medicine (T.D.), School of Medicine (Kastamonu), Hacettepe University, Ankara, Turkey.
Tuncay
T
Delibasi
D001862:Bone Resorption / Q000517:prevention & control*; D005260:Female; D052216:Glucagon-Like Peptide 1 / Q000031:analogs & derivatives*; D006801:Humans; D009765:Obesity / Q000188:drug therapy*; D010012:Osteogenesis / Q000187:drug effects*; D018027:Receptors, Glucagon / Q000819:agonists*; D015431:Weight Loss
D018027:Receptors, Glucagon; D052216:Glucagon-Like Peptide 1